Natco Pharma announces tentative approval for Armodafinil 50mg, 150mg, and 250mg Tablets

From USFDA

Natco Pharma announced that its marketing partner in the USA, Breckenridge Pharmaceutical Inc., has received tentative approval from the United States Food & Drug Adminstration (USFDA) for Armodafinil 50mg, 150mg, and 250mg Tablets

Powered by Capital Market - Live News